Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group).

Basnyat, B; Holck, P; Pun, M; Halverson, S; Szawarski, P; Gertsch, J; Steif, M; Powell, S; Khanal, S; Joshi, A; Shankar, R; Karambay, J; Alexander, H; Stone, A; Morrissey, C; Thompson, B; Farrar, J

Journal article

Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group).

Abstract:: OBJECTIVES: Over the last 20 years a number of small trials have reported that spironolactone effectively prevents acute mountain sickness (AMS), but to date there have been no large randomized trials investigating the efficacy of spironolactone in prevention of AMS. Hence, a prospective, double-blind, randomized, placebo-controlled trial was conducted to evaluate the efficacy of spironolactone in the prevention of AMS. METHODS: Participants were sampled from a diverse population of western ...
Expand abstract
Collapse abstract

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Basnyat, B., Holck, P., Pun, M., Halverson, S., Szawarski, P., Gertsch, J., Steif, M., Powell, S., Khanal, S., Joshi, A., Shankar, R., Karambay, J., Alexander, H., Stone, A., Morrissey, C., Thompson, B., & Farrar, J. (2011). Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group). Wilderness and Environmental Medicine, 22(1), 15–22.

MLA Style

Basnyat, B., et al. “Spironolactone Does Not Prevent Acute Mountain Sickness: a Prospective, Double-Blind, Randomized, Placebo-Controlled Trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group).” Wilderness and Environmental Medicine, vol. 22, no. 1, 2011, pp. 15–22.

Chicago Style

Basnyat, B, P Holck, M Pun, S Halverson, P Szawarski, J Gertsch, M Steif, et al. 2011. “Spironolactone Does Not Prevent Acute Mountain Sickness: a Prospective, Double-Blind, Randomized, Placebo-Controlled Trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group).” Wilderness and Environmental Medicine 22 (1): 15–22.
Tweet
Print